COCRYSTAL PHARMA, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

Item 7.01 Regulation FD Disclosure

Beginning on January 11, 2021, senior executives of Cocrystal Pharma, Inc. (the "Company") will participate in the BioConnect 2021 Conference hosted by H.C. Wainwright & Co., LLC and make presentations to certain members of the investment community. A copy of the Company's presentation to be used at this conference is being furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The presentation is also available on the Company's website at www.cocrystalpharma.com.

The information in this Item 7.01 (including Exhibit 99.1) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities under such section, and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, or the Exchange Act.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits



Exhibit   Description

99.1        Cocrystal Pharma, Inc. Investor Presentation, dated January 2021

© Edgar Online, source Glimpses